Mesothelioma Applied Research Foundation (Meso Foundation) is a leading advocate of research, training and financing of mesothelioma. As a nonprofit organization, the Fund continues its efforts through the support of fellow lawyers mesothelioma, including patients, doctors, lawyers and pharmaceutical companies. The Foundation has concentrated its resources to support patients while rigorously working towards healing.
Driven by the passionate conviction that the cure for malignant mesothelioma can be found, the Meso Foundation is working to exploit medical advances have been made in recent years. Foundation has launched several campaigns for federal funding in Washington, DC, raising awareness at national level. In addition, the organization provides political support for members of Congress who are involved in asbestos legislation beneficial.
While promoting the branches continue to raise awareness and encourage participation of the community, its research has studied many trials and has provided funding to more promising. In 2009, the Foundation received 56 grant applications and awarded a total of $ 800,000 to eight applicants.
Since its founding in 2000, the organization published a total of 62 Meso Foundation funds various research facilities around the world. Main recipients of the Memorial Sloan-Kettering Cancer Center and Dr. Mitchell Ho and the National Cancer Institute.
As part of its attempt to spread awareness about the rare cancer, the Meso-America Foundation is hosting a symposium on the disease of mesothelioma in Washington DC between 23 and 25 June 2011. Held at the Omni Shoreham Hotel, the three-day conference is open to patients, families, caregivers, health professionals and other advocates of mesothelioma. Functioning as an opportunity both to peer networks and a source of information on the current approach of the medical community for cancer, this conference aims to empower participants through the sharing of knowledge.
Covering topics such as chemotherapy intra-cavity, gene therapy and immunotherapy, the Conference brings together the science and support for everyone involved. Registration for the event begins March 15, 2011. Those unable to participate in this seminar have access to other resources through the online archives of the Fund.
Driven by the passionate conviction that the cure for malignant mesothelioma can be found, the Meso Foundation is working to exploit medical advances have been made in recent years. Foundation has launched several campaigns for federal funding in Washington, DC, raising awareness at national level. In addition, the organization provides political support for members of Congress who are involved in asbestos legislation beneficial.
While promoting the branches continue to raise awareness and encourage participation of the community, its research has studied many trials and has provided funding to more promising. In 2009, the Foundation received 56 grant applications and awarded a total of $ 800,000 to eight applicants.
Since its founding in 2000, the organization published a total of 62 Meso Foundation funds various research facilities around the world. Main recipients of the Memorial Sloan-Kettering Cancer Center and Dr. Mitchell Ho and the National Cancer Institute.
As part of its attempt to spread awareness about the rare cancer, the Meso-America Foundation is hosting a symposium on the disease of mesothelioma in Washington DC between 23 and 25 June 2011. Held at the Omni Shoreham Hotel, the three-day conference is open to patients, families, caregivers, health professionals and other advocates of mesothelioma. Functioning as an opportunity both to peer networks and a source of information on the current approach of the medical community for cancer, this conference aims to empower participants through the sharing of knowledge.
Covering topics such as chemotherapy intra-cavity, gene therapy and immunotherapy, the Conference brings together the science and support for everyone involved. Registration for the event begins March 15, 2011. Those unable to participate in this seminar have access to other resources through the online archives of the Fund.
